Recent developments in tubulin polymerization inhibitors: An overview

被引:296
作者
Kaur, Ramandeep [1 ]
Kaur, Gurneet [1 ]
Gill, Rupinder Kaur [1 ,2 ]
Soni, Richard [1 ]
Bariwal, Jitender [1 ]
机构
[1] ISF Coll Pharm, Dept Pharmaceut Chem, Moga 142001, Punjab, India
[2] Punjab Tech Univ, Kapurthala 144601, Punjab, India
关键词
Tubulin polymerization; Tubulin polymerization inhibitors; Microtubules; Disruption of microtubules; VASCULAR-TARGETING AGENT; COLCHICINE-BINDING-SITE; BIOLOGICAL EVALUATION; COMBRETASTATIN A-4; ISOCOMBRETASTATIN A-4; BENZOSUBERENE ANALOGS; MICROTUBULE DYNAMICS; ANTIMITOTIC AGENTS; ANTITUMOR-ACTIVITY; STRUCTURAL BASIS;
D O I
10.1016/j.ejmech.2014.09.051
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Microtubules are protein biopolymers formed through polymerization of heterodimers of alpha- and beta-tubulins. Disruption of microtubules can induce cell cycle arrest in G(2)-M phase and formation of abnormal mitotic spindles. Their importance in mitosis and cell division makes microtubules an attractive target for anticancer drug discovery. A number of naturally occurring compounds such as paclitaxel, epothilones, vinblastine, combretastatin, and colchicines exert their effect by changing dynamics of tubulin such as polymerization and depolymerization. During past few years, rapid development of the novel tubulin polymerization inhibitors has been witnessed. Diverse classes of chemical compounds from the natural as well as from the synthetic origin have been extensively studied. This review highlights the various classes of synthetically derived chemical compounds those have been reported in last few years as potential tubulin polymerization inhibitors. A brief synthetic methodology to access these compounds has been highlighted along with the brief SAR studies. We strongly believe that this review will provide a platform to the synthetic chemists and biologists to design and synthesize new and potent compounds to inhibit the tubulin polymerization. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:89 / 124
页数:36
相关论文
共 129 条
[81]   Pharmaceutical development of anticancer agents derived from marine sources [J].
Nuijen, B ;
Bouma, M ;
Manada, C ;
Jimeno, JM ;
Schellens, JHM ;
Bult, A ;
Beijnen, JH .
ANTI-CANCER DRUGS, 2000, 11 (10) :793-811
[82]   Synthesis of combretastatin A4 analogues on steroidal framework and their anti-breast cancer activity [J].
Parihar, Swati ;
Kumar, Amit ;
Chaturvedi, Amit K. ;
Sachan, Naresh Kumar ;
Luqman, Suaib ;
Changkija, Bendangla ;
Manohar, Murli ;
Prakash, Om ;
Chanda, D. ;
Khan, Feroz ;
Chanotiya, C. S. ;
Shanker, Karuna ;
Dwivedi, Anila ;
Konwar, Rituraj ;
Negi, Arvind S. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 137 :332-344
[83]   New substituted 4H-chromenes as anticancer agents [J].
Patil, Shivaputra A. ;
Wang, Jin ;
Li, Xiaochen S. ;
Chen, Jianjun ;
Jones, Terreia S. ;
Hosni-Ahmed, Amira ;
Patil, Renukadevi ;
Seibel, William L. ;
Li, Wei ;
Miller, Duane D. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (13) :4458-4461
[84]   Review: Tubulin function, action of antitubulin drugs, and new drug development [J].
Pellegrini, F ;
Budman, DR .
CANCER INVESTIGATION, 2005, 23 (03) :264-273
[85]   Antiangiogen concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells [J].
Pourroy, B ;
Honoré, S ;
Pasquier, E ;
Bourgarel-Rey, V ;
Kruczynski, A ;
Briand, C ;
Braguer, D .
CANCER RESEARCH, 2006, 66 (06) :3256-3263
[86]  
Rai A., 2012, PLOS ONE, V7
[87]   Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted isocombretastatin A-4 analogs [J].
Rasolofonjatovo, Evelia ;
Provot, Olivier ;
Hamze, Abdallah ;
Rodrigo, Jordi ;
Bignon, Jerome ;
Wdzieczak-Bakala, Joanna ;
Lenoir, Christine ;
Desravines, Deborah ;
Dubois, Joelle ;
Brion, Jean-Daniel ;
Alami, Mouad .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 62 :28-39
[88]   Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activity [J].
Rasolofonjatovo, Evelia ;
Provot, Olivier ;
Hamze, Abdallah ;
Rodrigo, Jordi ;
Bignon, Jerome ;
Wdzieczak-Bakala, Joanna ;
Desravines, Deborah ;
Dubois, Joelle ;
Brion, Jean-Daniel ;
Alami, Mouad .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 52 :22-32
[89]   Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain [J].
Ravelli, RBG ;
Gigant, B ;
Curmi, PA ;
Jourdain, I ;
Lachkar, S ;
Sobel, A ;
Knossow, M .
NATURE, 2004, 428 (6979) :198-202
[90]   Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy [J].
Raymond, E ;
Faivre, S ;
Armand, JP .
DRUGS, 2000, 60 (Suppl 1) :15-23